1/30/2023 7:39:19 AM
Moderna Granted FDA Breakthrough Therapy Designation For RSV Vaccine Candidate MRNA-1345
1/9/2023 8:12:50 AM
Moderna 2022 COVID-19 Vaccine Sales $18.4 Bln; Still Sees Minimum COVID-19 Vaccine Sales Of $5.0 Bln In 2023
1/4/2023 7:46:44 AM
Moderna Agrees To Buy OriCiro For $85 Mln
12/19/2022 9:34:50 AM
ATN Increases Quarterly Dividend By 24% To $0.21/shr; Payable January 6/ Record December 31
12/16/2022 7:58:09 AM
EMA's CHMP Recommends Use Of Moderna's BA.1 Targeting Bivalent COVID-19 Booster In Children
12/13/2022 7:30:39 AM
Moderna And Merck Say Phase 2b KEYNOTE-942/mRNA-4157-P201 Trial Of MRNA-4157/V940 Meets Primary Endpoint
11/14/2022 8:15:01 AM
Moderna:BA.4/BA.5 Targeting Bivalent Booster Meets Main Goal Of Superiority Against Omicron Variants
11/10/2022 8:10:41 PM
Harbour BioMed Enters Into License And Collaboration Agreement With Moderna
11/3/2022 7:04:47 AM
Moderna Q3 Revenues Of $3.4 Bln; GAAP Net Income Of $1.0 Bln